Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Covetrus, Inc. stock logo
CVET
Covetrus
$20.99
$20.97
$13.39
$21.20
$2.94B1.511.34 million shs3 shs
CVS Health Co. stock logo
CVS
CVS Health
$67.76
-1.1%
$74.80
$64.41
$83.25
$85.41B0.5210.73 million shs8.65 million shs
Express Scripts Holding stock logo
ESRX
Express Scripts
$92.33
$92.33
$66.93
$101.73
$52.06B0.886.64 million shs31.61 million shs
PetMed Express, Inc. stock logo
PETS
PetMed Express
$4.13
-0.5%
$4.75
$4.01
$16.18
$87.35M0.68376,543 shs335,231 shs
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$17.81
-1.3%
$20.19
$17.51
$35.54
$15.36B0.7313.98 million shs10.26 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Covetrus, Inc. stock logo
CVET
Covetrus
0.00%0.00%0.00%0.00%0.00%
CVS Health Co. stock logo
CVS
CVS Health
-1.08%-1.20%-14.22%-5.88%-7.01%
Express Scripts Holding stock logo
ESRX
Express Scripts
0.00%0.00%0.00%0.00%0.00%
PetMed Express, Inc. stock logo
PETS
PetMed Express
-0.48%-2.13%-13.24%-39.71%-72.76%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-1.33%+1.02%-13.67%-22.93%-48.95%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Covetrus, Inc. stock logo
CVET
Covetrus
N/AN/AN/AN/AN/AN/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
5 of 5 stars
4.43.03.33.93.72.53.8
Express Scripts Holding stock logo
ESRX
Express Scripts
N/AN/AN/AN/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
2.3406 of 5 stars
3.02.00.00.01.21.72.5
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
4.5407 of 5 stars
3.93.02.52.33.23.30.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Covetrus, Inc. stock logo
CVET
Covetrus
N/AN/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
2.80
Moderate Buy$89.4432.00% Upside
Express Scripts Holding stock logo
ESRX
Express Scripts
N/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
2.00
Hold$13.25220.82% Upside
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
1.87
Reduce$24.3636.76% Upside

Current Analyst Ratings

Latest ESRX, WBA, CVS, CVET, and PETS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
4/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$83.00 ➝ $76.00
4/4/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
4/3/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $22.00
4/3/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$37.00 ➝ $35.00
4/3/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$25.00 ➝ $22.00
4/1/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$21.00 ➝ $20.00
4/1/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$25.00
3/26/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
3/26/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$23.00 ➝ $22.00
3/26/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$22.00 ➝ $21.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Covetrus, Inc. stock logo
CVET
Covetrus
$4.58B0.64$2.19 per share9.59$10.97 per share1.91
CVS Health Co. stock logo
CVS
CVS Health
$357.78B0.24$11.83 per share5.73$59.55 per share1.14
Express Scripts Holding stock logo
ESRX
Express Scripts
$100.06B0.52$10.49 per share8.80$32.00 per share2.89
PetMed Express, Inc. stock logo
PETS
PetMed Express
$256.86M0.34$0.54 per share7.69$5.22 per share0.79
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$139.08B0.11$6.45 per share2.76$17.61 per share1.01

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Covetrus, Inc. stock logo
CVET
Covetrus
-$54M-$0.10N/A20.78N/A-0.28%6.83%3.01%N/A
CVS Health Co. stock logo
CVS
CVS Health
$8.34B$6.4610.497.460.922.33%15.25%4.55%5/1/2024 (Confirmed)
Express Scripts Holding stock logo
ESRX
Express Scripts
$4.52B$7.1013.009.721.164.83%25.43%8.94%N/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$5.14M-$0.39N/A41.30N/A-2.92%-1.25%-0.75%5/27/2024 (Estimated)
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-$3.08B-$7.00N/A5.691.13-4.18%12.11%3.23%6/25/2024 (Estimated)

Latest ESRX, WBA, CVS, CVET, and PETS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
CVS Health Co. stock logo
CVS
CVS Health
$1.69N/A-$1.69N/AN/AN/A  
3/28/2024Q2 24
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.82$1.20+$0.38$9.25$35.86 billion$37.05 billion      
2/7/202412/31/2023
CVS Health Co. stock logo
CVS
CVS Health
$2.01$2.12+$0.11$2.66$90.58 billion$93.81 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Covetrus, Inc. stock logo
CVET
Covetrus
N/AN/AN/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
$2.663.93%+6.56%41.18%2 Years
Express Scripts Holding stock logo
ESRX
Express Scripts
N/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/AN/A-6.75%N/AN/A
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$1.005.61%+1.25%N/A N/A

Latest ESRX, WBA, CVS, CVET, and PETS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2024
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.39%4/19/20244/22/20245/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Covetrus, Inc. stock logo
CVET
Covetrus
0.65
1.88
1.08
CVS Health Co. stock logo
CVS
CVS Health
0.77
0.86
0.63
Express Scripts Holding stock logo
ESRX
Express Scripts
0.63
0.77
0.65
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
1.32
0.84
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.50
0.66
0.32

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Covetrus, Inc. stock logo
CVET
Covetrus
92.20%
CVS Health Co. stock logo
CVS
CVS Health
80.66%
Express Scripts Holding stock logo
ESRX
Express Scripts
84.87%
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
58.59%

Insider Ownership

CompanyInsider Ownership
Covetrus, Inc. stock logo
CVET
Covetrus
0.40%
CVS Health Co. stock logo
CVS
CVS Health
0.24%
Express Scripts Holding stock logo
ESRX
Express Scripts
0.79%
PetMed Express, Inc. stock logo
PETS
PetMed Express
3.60%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
17.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Covetrus, Inc. stock logo
CVET
Covetrus
5,710140.12 million139.56 millionNot Optionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.26 billionOptionable
Express Scripts Holding stock logo
ESRX
Express Scripts
N/A563.86 millionN/AOptionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
30221.15 million20.39 millionOptionable
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
331,000862.71 million712.60 millionOptionable

ESRX, WBA, CVS, CVET, and PETS Headlines

SourceHeadline
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy servicesWalgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
cnbc.com - April 25 at 12:04 AM
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy BusinessWalgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
businesswire.com - April 24 at 11:55 PM
DoorDash and Walgreens Launch Unprecedented Access for SNAP CustomersDoorDash and Walgreens Launch Unprecedented Access for SNAP Customers
businesswire.com - April 24 at 9:00 AM
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting WealthThe Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com - April 24 at 7:25 AM
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by South Dakota Investment CouncilWalgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by South Dakota Investment Council
marketbeat.com - April 23 at 9:18 PM
Mengis Capital Management Inc. Sells 42,100 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)Mengis Capital Management Inc. Sells 42,100 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
marketbeat.com - April 22 at 2:45 PM
Beat the Dow Jones With This Cash-Gushing Dividend StockBeat the Dow Jones With This Cash-Gushing Dividend Stock
fool.com - April 21 at 7:21 AM
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Given Average Rating of "Reduce" by AnalystsWalgreens Boots Alliance, Inc. (NASDAQ:WBA) Given Average Rating of "Reduce" by Analysts
americanbankingnews.com - April 21 at 2:30 AM
Capital Management Corp VA Has $10.87 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)Capital Management Corp VA Has $10.87 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
marketbeat.com - April 20 at 7:04 PM
6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer
247wallst.com - April 19 at 9:41 AM
6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer
247wallst.com - April 19 at 9:41 AM
Walgreens will lay off more workersWalgreens will lay off more workers
supermarketnews.com - April 18 at 1:04 PM
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday April 27Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday April 27
businesswire.com - April 18 at 12:00 PM
Walgreens Layoffs 2024: What to Know About the Latest WBA Job CutsWalgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts
investorplace.com - April 18 at 11:05 AM
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Boosted by Sumitomo Mitsui Trust Holdings Inc.Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Boosted by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - April 18 at 6:13 AM
What the Options Market Tells Us About Walgreens Boots AllianceWhat the Options Market Tells Us About Walgreens Boots Alliance
benzinga.com - April 17 at 4:51 PM
KLCM Advisors Inc. Sells 98,432 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)KLCM Advisors Inc. Sells 98,432 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
marketbeat.com - April 17 at 1:39 PM
Walgreens Boots Alliance (NASDAQ:WBA) Hits New 52-Week Low at $17.53Walgreens Boots Alliance (NASDAQ:WBA) Hits New 52-Week Low at $17.53
marketbeat.com - April 17 at 1:11 PM
Walgreens Boots Alliance advances sustainable packaging targetsWalgreens Boots Alliance advances sustainable packaging targets
packaging-gateway.com - April 17 at 11:50 AM
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on ItWalgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 17 at 10:05 AM
Walgreens Boots Alliances Progress in Sustainable PackagingWalgreens Boots Alliance's Progress in Sustainable Packaging
finance.yahoo.com - April 16 at 12:54 PM
Louisiana State Employees Retirement System Invests $2.92 Million in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)Louisiana State Employees Retirement System Invests $2.92 Million in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
marketbeat.com - April 16 at 6:51 AM
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director Inderpal S. Bhandari Purchases 3,000 SharesWalgreens Boots Alliance, Inc. (NASDAQ:WBA) Director Inderpal S. Bhandari Purchases 3,000 Shares
americanbankingnews.com - April 16 at 4:46 AM
Inderpal S. Bhandari Acquires 3,000 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) StockInderpal S. Bhandari Acquires 3,000 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock
insidertrades.com - April 16 at 4:39 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Covetrus logo

Covetrus

NASDAQ:CVET
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Express Scripts logo

Express Scripts

NASDAQ:ESRX
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
PetMed Express logo

PetMed Express

NASDAQ:PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Walgreens Boots Alliance logo

Walgreens Boots Alliance

NASDAQ:WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.